All In Biotech

Drug Trial Radar · NCT06771219

SLV-154 Treatment of Advanced Cancers

A Phase 1 Dose-Escalation/Expansion Study of SLV-154 in Subjects With Advanced Cancers

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

May 14, 2025

Primary completion

Aug 2027

Study completion Nov 2027

Sponsor

Lead sponsor
Solve TherapeuticsIndustry
Sponsor type
Industry
First posted
Jan 13, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 1 study comprising a Phase 1a dose-escalation portion and a Phase 1b expansion portion evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with advanced solid tumors.

Conditions

  • Advanced Cancer
  • Advanced Solid Tumor
  • Metastatic Cancer

Interventions

  • SLV-154Drug

    SLV-154

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1a: MTD and/or RDRTime frame: Through the duration of treatment, up to approximately 18 months
  2. Phase 1b: Objective response rate (ORR)Time frame: Through the duration of treatment, up to approximately 18 months

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Precision NextGen Oncology and Research Center

    Beverly Hills, California · Recruiting

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California · Recruiting

  • Sarcoma Oncology Research Center

    Santa Monica, California · Recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • Astera Cancer Care

    East Brunswick, New Jersey · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • The James Outpatient Care West Center

    Columbus, Ohio · Recruiting

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania · Recruiting

  • MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Oncology Consultants

    Houston, Texas · Recruiting

  • Mays Cancer Center; University of Texas Health San Antonio

    San Antonio, Texas · Recruiting

  • University of Washington / Fred Hutchinson Cancer Center

    Seattle, Washington · Recruiting

  • Northwest Medical Specialties, PLLC

    Tacoma, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.